The relationship among oral and systemic health and HIV shedding in saliva is not well-understood. We hypothesized that oral and systemic health are associated with HIV shedding in saliva of HIV-infected women. Saliva from 127 participants enrolled in the Women’s Interagency HIV Study (WIHS) was collected at repeated visits over a 5½-year study period (October 1998 through March 2004) and was evaluated for HIV-1 RNA. Demographic, lifestyle, and systemic and oral health characteristics were evaluated as possible correlates of salivary HIV-1 shedding. Multivariate models showed significantly increased risk of HIV-1 shedding in saliva as blood levels of CD4 cell counts decreased (p < 0.0001) and HIV RNA increased (p < 0.0001). Diabetes (p = 0.002) and a high proportion of gingival bleeding sites (p = 0.01) were associated with increased likelihood, while anti-retroviral therapy (p = 0.0003) and higher levels of stimulated saliva flow rates (p = 0.02) were associated with a lower likelihood of HIV-1 RNA shedding in saliva.
AlvesMMulliganRPassaroDGawellSNavazeshMPhelanJ. (2006). Longitudinal evaluation of loss of attachment in HIV-infected women compared to HIV-uninfected women. J Periodontol77:773-779.
2.
BarkanSEMelnickSLPreston-MartinSWeberKKalishLAMiottiP. (1998). The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology9:117-125.
3.
BaronSPoastJCloydMW (1999). Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med159:303-310.
4.
BarrCEMillerLKLopezMRCroxsonTSSchwartzSADenmanH. (1992). Recovery of infectious HIV-1 from whole saliva. J Am Dent Assoc123:36-37, 39-48.
5.
BarrCEQureshiMNQiuZKaimJZhangW (1996). Oral HIV-I recovery in the presence of periodontal disease. Oral Dis2:198-201.
6.
CampoJPereaMAdel RomeroJCanoJHernandoVBasconesA (2006). Oral transmission of HIV, reality or fiction? An update. Oral Dis12:219-228.
7.
CohenMSHellmannNLevyJADeCockKLangeJ (2008). The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest118:1244-1254.
8.
FreelSAFiscusSAPilcherCDMenezesPGinerJPatrickE. (2003). Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. AIDS17:2025-2033.
9.
GandhiMKoelleDMAmeliNBacchettiPGreenspanJSNavazeshM. (2004). Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res83:639-643.
10.
GreenspanDKomaroffERedfordMPhelanJANavazeshMAlvesME. (2000). Oral mucosal lesions and HIV viral load in the Women’s Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr25:44-50.
11.
GreenspanDGangeSJPhelanJANavazeshMAlvesMEMacPhailLA. (2004). Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res83:145-150.
12.
HabteHHMallASde BeerCLotzZEKahnD (2006). The role of crude human saliva and purified salivary Muc5b and Muc7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay. Virol J3:99.
13.
HallHISongRRhodesPPrejeanJAnQLeeLM. (2008). Estimation of HIV incidence in the United States. JAMA300:520-529.
14.
LinALJohnsonDAStephanKTYehCK (2004). Salivary secretory leukocyte protease inhibitor increases in HIV infection. J Oral Pathol Med33:410-416.
15.
LiuzziGChirianniAClementiMBagnarelliPValenzaACataldoPT. (1996). Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS10:F51-F56.
16.
MaticicMPoljakMKramarBTomazicJVidmarLZakotnikB. (2000). Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease. J Dent Res79:1496-1501.
17.
MulliganRNavazeshMKomaroffEGreenspanDRedfordMAlvesM. (2000). Salivary gland disease in Human Immunodeficiency Virus-positive women from the WIHS Study. Women’s Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod89:702-709.
18.
MulliganRPhelanJABrunelleJRedfordMPogodaJMNelsonE. (2004). Baseline characteristics of participants in the oral health component of the Women’s Interagency HIV Study. Community Dent Oral Epidemiol32:86-98.
19.
NavazeshMChristensenCM (1982). A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res61:1158-1162.
20.
NavazeshMMulliganRKomaroffERedfordMGreenspanDPhelanJ (2000). The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res79:1502-1507.
21.
NavazeshMMulliganRBarronYRedfordMGreenspanDAlvesM. (2003). A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women’s Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod95:693-698.
22.
NavazeshMMulliganRKarimRMackWJRamSSeirawanH. (2009). Effect of HAART on salivary gland function in the Women’s Interagency HIV Study (WIHS). Oral Dis15:52-60.
23.
NowickiMJBenningLBremerJWMeyerWA3rdHansonCBrambillaD. (2001). Longitudinal variability of Human Immunodeficiency Virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and Nuclisens assays in a large multicenter study. J Clin Microbiol39:3760-3763.
24.
PhelanJAMulliganRNelsonEBrunelleJAlvesMENavazeshM. (2004). Dental caries in HIV-seropositive women. J Dent Res83:869-873.
25.
SchackerTCollierACHughesJSheaTCoreyL (1996). Clinical and epidemiologic features of primary HIV infection. Ann Intern Med125:257-264.
26.
ScullyCPorterS (2000). HIV topic update: oro-genital transmission of HIV. Oral Dis6:92-98.
27.
ShugarsDCWahlSM (1998). The role of the oral environment in HIV-1 transmission. J Am Dent Assoc129:851-858.
28.
ShugarsDCSladeGDPattonLLFiscusSA (2000). Oral and systemic factors associated with increased levels of Human Immunodeficiency Virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod89:432-440.
29.
ShugarsDCSweetSPMalamudDKazmiSHPage-ShaferKChallacombeSJ (2002). Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis8(Suppl 2):169-175.
30.
YavuzyilmazEYumakOAkdoganliTYamalikNÖzerNErsoyF. (1996). The alterations of whole saliva constituents in patients with diabetes mellitus. Aust Dent J41:193-197.
31.
YeungSCKazaziFRandleCGHowardRCRizviNDownieJC. (1993). Patients infected with Human Immunodeficiency Virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis167:803-809.
